Dr. Bradly Bussewitz, a foot and ankle fellowship-trained surgeon at Steindler Orthopedic Clinic in North Liberty, sees ...

Lightning technology expands upon Treace’s market-leading Lapiplasty ® System with advanced new instrumentation designed to reduce surgical steps, precisely correct in all three planes, and further ...

Scientists believe bunions may form due to family history, having low arches, and wearing unsupportive footwear ...

Bunions are one of the most common, and often painful, foot deformities. They are characterized by a bony bump forming on the ...

Trip Taylor: Good afternoon, everyone, and welcome to our third quarter 2025 earnings conference call. Participating from the company today will be John Treace, Chief Executive Officer; and Mark Hair, ...

CEO Treace stated, "we are not growing our line the way we anticipated for the year," while also noting case volume growth in Q3 2025 was still below original expectations and driven by lower-ASP ...

Growth was mainly driven by an increase in bunion procedure kits sold compared to the prior year. Gross margin was 79.1% in 2025 compared to 80.1% in 2024. Total operating expenses were $55.4 million ...

Good morning, everybody. We're going to go ahead and get started. Thanks for joining us today for Treace Medical's Investor Day Event. I'm John Treace, CEO and Chairman of the company. And it's really ...

– Treatment with the selective NaV1.8 pain signal inhibitor VX-993 after bunionectomy surgery did not meet the primary endpoint – – Treatment with VX-993 was generally safe and well tolerated, with ...